Pharmacists in Carpinteria, California


13 Pharmacists found in Carpinteria
male pharmacist

Dr. Albert Wu, PHARMD


Pharmacist
1036 Casitas Pass Rd, Carpinteria, CA 93013
805-684-0260    

female pharmacist

Dr. Brittany Tayler League, PHARMD


Pharmacist
1036 Casitas Pass Rd, Carpinteria, CA 93013
805-684-0260    

male pharmacist

Mr. Carl Barnett


Pharmacist
1018 Casitas Pass Rd, Carpinteria, CA 93013
805-684-8367     805-684-8848



female pharmacist

Caroline Duxburysmith, RPH


Pharmacist
1018 Casitas Pass Rd, Carpinteria, CA 93013
805-684-8367     805-684-8848

male pharmacist

James Bao Nguyen, PHARM.D./M.B.A


Pharmacist
850 Linden Ave, Carpinteria, CA 93013
805-684-4124    

female pharmacist

Jessica Ryan Rohan, PHARMD


Pharmacist
1018 Casitas Pass Rd, Carpinteria, CA 93013
805-684-8367    

male pharmacist

Justin Charles Lussier, PHARMD


Pharmacist
1036 Casitas Pass Rd, Carpinteria, CA 93013
805-684-0260    

male pharmacist

Lo Shia


Pharmacist
850 Linden Ave, Carpinteria, CA 93013
805-684-4124    

female pharmacist

Ms. Nadine Caffaro Tracy, RPH


Pharmacist
850 Linden Ave, Carpinteria, CA 93013
805-684-4124     805-684-2362

male pharmacist

Paul Clem Jr., RPH


Pharmacist
1018 Casitas Pass Rd, Carpinteria, CA 93013
805-684-8367     805-684-8848

male pharmacist

Richard Wardle


Pharmacist
801 Linden Ave, Carpinteria, CA 93013
805-684-4816     805-566-1369

female pharmacist

Rita Ohanian


Pharmacist
801 Linden Ave, Carpinteria, CA 93013
805-684-4816    

male pharmacist

Robert Zeyssig, PHARMD


Pharmacist
850 Linden Ave, Carpinteria, CA 93013
805-684-4124    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.